Corporate News Acadia Pharma GAAP EPS of $0.20 beats by $0.06, revenue of $250.4M beats by $1.56M by Contributor since / Followers 7 hours ago Acadia Pharma press release (NASDAQ:ACAD): Q3 GAAP EPS of $0.20 beats by $0.06. Revenue of $250.4M (+18.3% Y/Y) beats by $1.56M. Tags: ACAD Continue Reading Previous SA Asks: How will the U.S. election results impact healthcare stocks?Next SolarEdge Technologies Non-GAAP EPS of -$15.30 misses by $13.66, revenue of $260.9M misses by $9.99M Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ